GLP-1 and Hormone Panel: Testosterone, Estrogen, Thyroid
How weight loss on GLP-1 medications reshapes your hormonal profile -- and what to test.
Weight loss does not just change your waistline -- it fundamentally reshapes your hormonal landscape. GLP-1 medications produce hormonal improvements that many patients find as life-changing as the weight loss itself.
Hormone Changes in Men
Men's Hormone Panel on GLP-1
| Test | Typical Change | When to Test |
|---|---|---|
| Total testosterone | +100-200 ng/dL increase | Baseline, 6mo, 12mo |
| Free testosterone | Proportional increase | Baseline, 6mo, 12mo |
| SHBG | Often increases | Baseline, 12mo |
| Estradiol | Decreases (less aromatization) | If symptomatic |
| LH, FSH | May normalize | If hypogonadal |
For men with obesity-related low testosterone, weight loss on GLP-1 often restores testosterone to normal levels without requiring TRT. Reduced abdominal fat decreases aromatase activity (the enzyme that converts testosterone to estrogen), directly improving the testosterone-to-estrogen ratio.
Hormone Changes in Women
Women's Hormone Panel on GLP-1
| Test | Typical Change | When to Test |
|---|---|---|
| Total testosterone (PCOS) | Decreases toward normal | Baseline, 6mo |
| DHEA-S (PCOS) | Often decreases | Baseline, 6mo |
| Estradiol | May shift with weight loss | If cycle changes |
| AMH (fertility) | May improve in PCOS | If fertility concern |
| LH/FSH ratio (PCOS) | Often normalizes | Baseline, 6mo |
For women with PCOS, the hormonal improvements can be dramatic: reduced androgens lead to less acne, less excess hair, and restored ovulation and menstrual regularity.
Thyroid Monitoring (Everyone)
Thyroid Panel
- TSH: Baseline and every 6-12 months (GLP-1 class boxed warning relates to thyroid C-cell tumors in rodents)
- Free T4: If TSH abnormal
- Levothyroxine users: May need dose reduction as weight decreases (dosing is weight-based)
- Contraindication: Personal or family history of medullary thyroid carcinoma or MEN2
Monitor Your Hormonal Health
Trimi physicians track hormonal improvements alongside weight loss. Semaglutide $99/mo. Tirzepatide $125/mo.
Get StartedMedical Disclaimer
Hormonal changes vary by individual. Do not adjust hormone medications without physician guidance. This article is for informational purposes only.
More on GLP-1 lab monitoring
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).